Author: Jason Roth

The momentum behind Southern Nevada’s growing biotech ecosystem continues to gain national attention. A new feature in Vegas Inc highlights how Roseman Bioventures is helping shape that future—serving as what the publication describes as a “critical home” for emerging life science companies.

Read the full article

At its core, Roseman Bioventures was designed to solve one of the biggest challenges in biotech: bridging the gap between discovery and commercialization. Located on the Summerlin campus of Roseman University of Health Sciences, the 120,000-square-foot incubator provides startups with the space, infrastructure, and connections they need to move ideas out of the lab and into real-world applications.

The Vegas Inc story reinforces what we see every day—companies don’t just need lab space. They need an ecosystem. That includes access to capital, regulatory guidance, experienced mentors, and proximity to clinical partners. Roseman Bioventures brings all of that together under one roof, creating an environment where innovation can move faster and more efficiently.

As highlighted in the coverage, this model is already making an impact. By lowering barriers to entry and reducing the time and cost typically required to launch a biotech venture, Roseman Bioventures is helping attract companies to Las Vegas that might otherwise look to more established coastal hubs. Nevada’s pro-business climate and lower operating costs only strengthen that value proposition.

But beyond facilities and funding, what truly defines Roseman Bioventures is its role as a connector—linking entrepreneurs, researchers, investors, and healthcare providers in a way that accelerates progress and expands opportunity across the region.

Explore the full story to see how Roseman Bioventures is helping build the future of life sciences in Las Vegas.

Southern Nevada’s innovation community came together this week to celebrate the people and partnerships driving the region forward—and Roseman Bioventures was proud to be among those recognized.

Dr. Jeff Talbot, Vice President for Research at Roseman University of Health Sciences, and Titus Plattel, Managing Director of Roseman Bioventures, were named Ecosystem Partner of the Year at the Southern Nevada Innovation Awards, hosted by Desert Forge Ventures and the UNLV Office of Economic Development.

The awards ceremony, held at Black Fire Innovation, brought together leaders from research, investment, and industry to recognize the collaboration fueling growth across the region’s innovation economy.

This honor highlights the role Roseman Bioventures is playing in strengthening Southern Nevada’s life sciences and biotech ecosystem. Through its incubator model, Roseman Bioventures provides early-stage companies with access to lab space, research infrastructure, regulatory guidance, and connections to investors and industry partners—resources that are often out of reach for emerging startups.

“Recognition like this reflects the strength of collaboration across Southern Nevada,” said Talbot. “It’s a testament to what can be achieved when institutions, investors, and entrepreneurs work together to build something meaningful.”

As the region continues to gain momentum as a hub for innovation, Roseman Bioventures remains focused on accelerating the commercialization of life science discoveries and supporting companies as they grow from concept to clinical application.

The Southern Nevada Innovation Awards serve as a reminder that the future of innovation in the region is not built in isolation—it is powered by partnership.

---

Southern Nevada’s growing biotech ecosystem was in the spotlight this week, as leaders from research, investment, and industry joined Nevada Week to discuss the region’s expanding opportunities.

Hosted by Amber Renee Dixon, the segment featured Dr. Jeff Talbot, Vice President for Research at Roseman University; Len Jessup of Desert Forge Ventures; Ray Liu of Vena Vitals; and Jamie Schwartz of Biotech Vegas.

The conversation, which aired Thursday, April 23 at 5:30 p.m. on Vegas PBS, highlighted the rapid growth of the life sciences sector in Las Vegas and the critical role of collaboration in accelerating innovation.

A key focus of the discussion was Roseman Bioventures, Roseman University’s life sciences incubator, designed to support early-stage companies with the infrastructure, expertise, and connections needed to scale. Panelists emphasized how the region is building a more robust pipeline for biotech innovation—from research and development to investment and clinical application.

Ray Liu shared the story of Vena Vitals’ journey to Southern Nevada, pointing to the unique advantages of locating within Roseman Bioventures. He highlighted the company’s successful pathway—from establishing operations in Las Vegas to securing investment through Desert Forge Ventures—as a clear example of how the ecosystem is working.

Together, the panel underscored a shared vision: positioning Southern Nevada as a competitive and collaborative hub for biotech, where startups can grow faster and bring innovations to market more efficiently.

---

Roseman University of Health Sciences today announced the launch of Roseman Bioventures in Las Vegas to accelerate the translation of scientific breakthroughs into therapies and technologies that advance health.

Located on Roseman’s Summerlin campus, the 120,000-square-foot facility will serve as one of the largest dedicated life science incubators in the Intermountain West, providing startups and emerging companies with turnkey laboratories, research infrastructure, regulatory guidance, and connections to investors and industry partners, accelerating the path to commercialization.

 “Our vision for Roseman Bioventures is rooted in world-class research facilities that bridge the gap between research and commercial success,” said Jeff Talbot, PhD, Roseman University’s vice president for research. “We are expanding the Las Vegas ecosystem to support Nevada’s next generation of biotech leaders.”

Roseman Bioventures is a natural progression from the university’s successful Bioscience Collaborative, which has already attracted companies including Heligenics, Regenicin, VenaVitals, and WAVR Technologies to the Summerlin campus. Roseman Bioventures has assembled a growing team of local and national leaders in life science venture capital, finance, legal, and entrepreneurship. Through these partnerships, including Frax Finance, Desert Forge Ventures, Nevada Governor’s Office of Economic Development, Las Vegas Global Economic Alliance, and BioTech Vegas, Roseman Bioventures aims to solidify Southern Nevada as the center for biotech entrepreneurship in the Intermountain region. J.P. Morgan is a supporting sponsor providing financial, banking, and investment insights to member start-up companies.  

“Opportunities for life science startups in Nevada are tremendous from a regulatory and financial operational perspective, and we are excited to be part of the growing biotech ecosystem,” said Sam Kazemian, CEO of Frax Finance.

The launch comes as the U.S. life sciences sector continues to expand beyond traditional coastal hubs. Nevada’s pro-business environment, no state income tax, and rapidly growing population have positioned the state as an emerging destination for life science investment and innovation.

According to Talbot, compared to West and East Coast biotech corridors, Roseman Bioventures offers a cost advantage, making it an attractive incubator for early- to mid-stage life science companies.

“Access to investment opportunities is critical for a thriving life science startup ecosystem,” said Len Jessup, managing director of Desert Forge Ventures, a local venture capital enterprise that currently invests in several startups at Roseman Bioventures. “We look forward to continuing our close collaboration to make Southern Nevada a destination and foundry for life science technology and innovation, and to work with early-stage company founders to diversify and strengthen the region’s biotech community.”